Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +1.98% | +10.75% | +14.44% |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 30/04/20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 14/03/21 |
Steven N. Perrin
PSD | President | 59 | 13/09/20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 22/10/23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/22 |
Bryan E. Smith
CMP | Compliance Officer | 45 | 18/04/21 |
David Hovland
LAW | General Counsel | - | 18/04/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 30/04/17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 13/09/20 |
John S. McBride
BRD | Director/Board Member | 72 | 30/04/17 |
Steven N. Perrin
PSD | President | 59 | 13/09/20 |
Chief Executive Officer | 51 | 30/04/20 | |
James Robinson
BRD | Director/Board Member | 54 | 30/09/23 |
June Lee
BRD | Director/Board Member | 58 | 08/12/20 |
Jan Hillson
BRD | Director/Board Member | 71 | 01/07/21 |
Allan Kirk
BRD | Director/Board Member | - | 01/10/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 110,086 | 0 | 0 | 94.57 % |
Stock B | 1 | 24,813,130 | 23,466,868 ( 94.57 %) | 0 | |
Stock C | 0 | 4,422 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.44% | 51.12M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.67% | 22.15B | |
-17.37% | 21.02B | |
-9.03% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ELDN Stock
- Company Eledon Pharmaceuticals, Inc.